age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
61.25897
|
female
| 0
| 13
|
Lung Cancer
|
Cancer
| 1
| 19
|
under $11k
| 0
| 13,490
| 8,014.7656
| null | 7
|
black
| 29.398438
| 19
| 0.401978
| 0.104996
| 1
| 0
| 0
|
metastatic
| 0.4
| 0.5
|
dnr after sadm
| 1
| 87
| null | 110
| 10
| 36.69531
| 404.75
| 3
| null | 0.599976
| 131
| 7.449219
| null | null | null | 1
| null |
SIP>=30
| 1.1669
| 128
| 1
|
68.52295
|
male
| 0
| 9
|
Lung Cancer
|
Cancer
| 1
| 7
| null | 0
| 9,748
| 6,052.6523
| null | 15
|
white
| 18.699219
| 12
| 0.662964
| 0.360962
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.02
|
dnr after sadm
| 1
| 97
| 5.399414
| 100
| 20
| 36.09375
| null | 3.599609
| null | 1
| 144
| null | null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 17
| 1
|
86.64795
|
male
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 20
|
>$50k
| 0
| 8,987
| 5,409.3164
| null | 8.5
|
white
| 19.199219
| 28
| 0.748901
| 0.60498
| 1
| 0
| 0
|
no
| 0.6
| 0.4
|
dnr after sadm
| 2
| 90
| 13.398438
| 80
| 30
| 36.09375
| 204
| 3.699707
| 0.599976
| 1.699951
| 146
| 7.449219
| null | null | null | 1
| 5
|
<2 mo. follow-up
| 5
| 17
| 1
|
67.43298
|
male
| 0
| 20
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 10
| null | 0
| 29,192
| 17,898.7812
| null | 10
|
white
| 23.699219
| 36
| 0.771973
| 0.636963
| 5
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 20
| 53
| 7.899414
| 60
| 22
| 35.89844
| 532
| null | null | 1.599854
| 136
| 7.449219
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 414
| 1
|
85.06195
|
female
| 1
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 38,155
| 26,735.8125
| null | 30.333328
|
white
| 30.398438
| 38
| 0.507935
| 0.306946
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
dnr after sadm
| 13
| 68
| 12.599609
| 120
| 8
| 38.69531
| 163.3125
| 2.5
| 0.5
| 0.599976
| 142
| 7.479492
| null | null | null | 6
| null |
<2 mo. follow-up
| 4.527397
| 14
| 1
|
55.42499
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 7,515
| 4,379.293
| null | 17
|
black
| 19.898438
| 10
| 0.672974
| 0.373962
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.1
|
no dnr
| 6
| 100
| 4.099609
| 100
| 20
| 36.09375
| null | 3.299805
| null | 1
| 144
| null | null | null | null | 0
| 0
| null | 0
| 105
| 1
|
68.63794
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 6,801
| 4,078.2344
| null | 17
|
white
| 22.296875
| 33
| 0.779907
| 0.648926
| 1
| 0
| 0
|
yes
| 0.9
| 0.6
|
no dnr
| 5
| 53
| 15.898438
| 70
| 20
| 35.59375
| null | 3.699707
| null | 1.399902
| 140
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 3.108887
| 196
| 1
|
68.03595
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 27,335
| 13,538.8984
| null | 21
|
white
| 26.5
| 33
| 0.612915
| 0.507935
| 2
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
dnr after sadm
| 7
| 57
| 5.099609
| 82
| 28
| 38.29688
| 98.32812
| null | null | 0.799927
| 139
| 7.469727
| null | null | null | 7
| 5
|
no(M2 and SIP pres)
| 5
| 118
| 1
|
62.198
|
female
| 0
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
under $11k
| 0
| 62,019
| 41,464.5938
| null | 20.25
|
white
| 37.195313
| 41
| 0.462952
| 0.343994
| 8
| 1
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 32
| 45
| 20.898438
| 132
| 8
| 41.29688
| 162.5
| 2.699707
| null | 1
| 139
| 7.509766
| null | null | null | null | null |
SIP>=30
| 3.121094
| 1,258
| 1
|
87.72296
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
under $11k
| 9
| 16,386
| 7,860.3008
| null | 8.5
|
white
| 17.097656
| 26
| 0.790894
| 0.7229
| 2
| 1
| 0
|
no
| 0.8
| 0.6
|
dnr after sadm
| 5
| 61
| 10.298828
| 58
| 16
| 37.79688
| null | null | null | 0.699951
| 137
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 390
| 1
|
62.24197
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 9,470
| 5,086.2266
| null | 8
|
black
| 12.099609
| 9
| 0.887939
| 0.812988
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
no dnr
| 6
| 83
| 5.5
| 80
| 20
| 36.09375
| 316
| 3.199707
| 0.699951
| 1
| 139
| 7.429688
| null | null | null | 0
| 1
|
<2 mo. follow-up
| 1
| 42
| 1
|
66.80396
|
female
| 0
| 8
|
Lung Cancer
|
Cancer
| 2
| 12
|
$11-$25k
| 0
| 9,066
| 5,457.0195
| null | 7
|
white
| 12.699219
| 13
| 0.780884
| 0.542969
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 8
| 66
| 6.099609
| 104
| 24
| 37.39844
| null | 3.799805
| null | 1
| 142
| 7.429688
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 385
| 1
|
56.71198
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 6
|
under $11k
| 0
| 6,969
| 4,062.6348
| null | 13
|
white
| 18.199219
| 18
| 0.909912
| 0.848999
| 1
| 0
| 0
|
no
| 0.98
| 0.95
|
no dnr
| 6
| 97
| 14.099609
| 70
| 30
| 36.09375
| 232
| null | null | 1
| 141
| 7.359375
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,409
| 0
|
32.58899
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
|
$11-$25k
| 0
| 40,281
| 13,931.6719
| null | 27.333328
|
white
| 26.097656
| 20
| 0.872925
| 0.828979
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 18
| 113
| 12.599609
| 110
| 32
| 38.69531
| 130
| null | 1
| 0.899902
| 139
| 7.379883
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,001
| 1
|
72.83496
|
female
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| null |
under $11k
| 0
| 20,707
| 16,171.3594
| null | 25.333328
|
hispanic
| 22.898438
| 41
| 0.784912
| 0.655884
| 1
| 1
| 0
|
no
| 0.2
| 0.2
|
no dnr
| 14
| 64
| 11.798828
| 110
| 8
| 37.89844
| 248.3125
| 3.299805
| 0.399963
| 2
| 134
| 7.439453
| null | null | null | 4
| 4
|
SIP>=30
| 4
| 81
| 1
|
93.02399
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 24,818
| 14,741.2734
| null | 39
|
white
| 30.597656
| 46
| 0.487976
| 0.369995
| 3
| 1
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 3
| 47
| 10.898438
| 68
| 10
| 37.89844
| 210.1875
| 3
| 1
| 2.399902
| 132
| 7.369141
| null | null | null | null | null |
<2 mo. follow-up
| 3.266113
| 7
| 1
|
52.27698
|
female
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 14
|
$11-$25k
| 0
| 15,833
| 5,548.2305
| null | 41
|
white
| 42.296875
| 70
| 0.15097
| 0.072998
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 4
| 43
| 14.199219
| 140
| 36
| 36.29688
| 145
| 1.5
| 0.399963
| 0.399963
| 141
| 7.259766
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 6
| 1
|
66.50195
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 12
| null | 0
| 17,841
| 9,923.0312
| null | 12
|
white
| 22.398438
| 20
| 0.738892
| 0.589966
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
dnr after sadm
| 1
| 93
| 8.599609
| 120
| 20
| 36.09375
| 142.5
| 3.899902
| 0.599976
| 0.899902
| 139
| 7.429688
| null | null | null | null | null | null | 4.425781
| 165
| 1
|
47.258
|
male
| 0
| 26
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 30,794
| 19,494.3906
| null | 8.75
|
white
| 17.199219
| 11
| 0.743896
| 0.47998
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.125
|
dnr after sadm
| 9
| 93
| null | 110
| 20
| 37
| null | null | null | null | 140
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 27
| 1
|
75.20294
|
male
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 13
| null | 0
| 15,884
| 10,151.2031
| null | 10
|
white
| 21.597656
| 31
| 0.80896
| 0.690918
| 1
| 1
| 0
|
no
| 0.99
| 0.3
|
no dnr
| 13
| 70
| 7.799805
| 70
| 20
| 35
| null | 3.099609
| 0.899902
| 1.5
| 140
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 109
| 1
|
47.81699
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 11,059
| 6,199.6445
| null | 12
|
white
| 7.099609
| 11
| 0.876953
| 0.7229
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 4
| 74
| 7.5
| 80
| 16
| 36.89844
| null | 4
| 0.399963
| 1
| 141
| null | null | null | null | 0
| null |
SIP>=30
| 0.4948
| 734
| 1
|
64.29596
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 26,732
| 12,994.8281
| null | 14
|
white
| 18.898438
| 26
| 0.846924
| 0.794922
| 4
| 0
| 0
|
no
| null | null |
no dnr
| 15
| 55
| 7.899414
| 70
| 28
| 38.29688
| 197.5
| 3.299805
| 0.399963
| 0.599976
| 141
| 7.359375
| null | null | null | 4
| 6
|
adl>=4 (>=5 if sur)
| 6
| 1,396
| 0
|
62.987
|
female
| 0
| 14
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 35,581
| 17,470.0312
| null | 33.333313
|
black
| 35.695313
| 41
| 0.310974
| 0.129974
| 7
| 0
| 0
|
no
| 0.4
| 0.064
|
dnr after sadm
| 3
| 40
| 3
| 66
| 10
| 36.29688
| 219
| 2.799805
| 6.899414
| 0.699951
| 135
| 7.319336
| null | null | null | null | null |
<2 mo. follow-up
| 3.470215
| 19
| 1
|
44.42697
|
female
| 0
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
| null | 61
| 58,145
| 23,774
| null | 31
|
black
| 29.699219
| 45
| 0.577881
| 0.467957
| 1
| 1
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 28
| 130
| 15.099609
| 111
| 10
| 39.19531
| 142.5
| 2.599609
| 0.199982
| 6
| 142
| 7.479492
| null | null | null | null | 1
| null | 1
| 132
| 1
|
60.715
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 2
| 20
| null | 0
| 4,972
| 2,736.0762
| null | 8
|
white
| 16
| 18
| 0.837891
| 0.643921
| 1
| 1
| 0
|
metastatic
| 0.99
| 0.9
|
no dnr
| 5
| 103
| 5.399414
| 80
| 20
| 36.09375
| null | null | null | 0.899902
| 134
| null | null | null | null | 3
| 2
|
SIP>=30
| 2
| 892
| 1
|
20.04399
|
female
| 1
| 8
|
Coma
|
Coma
| 0
| null | null | 100
| 26,400
| 9,856.6875
| null | 32.5
|
white
| 30.597656
| 64
| 0.471985
| 0.399963
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 8
| 160
| 30.699219
| 173
| 12
| 40.39844
| 217.5
| 2.899902
| 0.5
| 3
| 134
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 2.353027
| 8
| 1
|
76.38098
|
male
| 0
| 59
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$11-$25k
| 100
| 91,340
| 62,352.2188
| null | 17
|
white
| 23.597656
| 43
| 0.237
| 0.135986
| 10
| 1
| 0
|
no
| 0.9
| 0.8
|
dnr after sadm
| 13
| 80
| 8
| 110
| 36
| 39.39844
| 161
| null | null | 1.299805
| 145
| 7.489258
| null | null | null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 1,390
| 0
|
83.05298
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 19
|
$11-$25k
| 0
| 11,650
| 5,398.1602
| null | 17.5
|
white
| 21.296875
| 57
| 0.73999
| 0.590942
| 1
| 1
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 9
| 51
| 6.199219
| 53
| 16
| 36.89844
| 237.03125
| 4.099609
| 0.399963
| 2
| 142
| 7.5
| null | null | null | 0
| 0
|
SIP>=30
| 0
| 1,387
| 0
|
44.42999
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 5
|
under $11k
| 9
| 23,510
| 12,153.7891
| null | 15.666664
|
white
| 18.097656
| 22
| 0.903931
| 0.868896
| 1
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 15
| 103
| 8.298828
| 68
| 24
| 38.59375
| 148
| 3.199707
| 1.799805
| 1.099854
| 145
| 7.379883
| null | null | null | 3
| null |
SIP>=30
| 2.511099
| 1,388
| 0
|
74.86896
|
female
| 1
| 4
|
Coma
|
Coma
| 2
| 14
| null | 100
| 4,332
| 2,538.168
| null | 3
|
white
| 19.699219
| 37
| 0.091995
| 0.053993
| 1
| 0
| 0
|
metastatic
| 0.05
| 0.000125
|
dnr after sadm
| 1
| 123
| 12.398438
| 80
| 40
| 35.39844
| 385
| null | null | 1
| 132
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
63.77298
|
male
| 0
| 3
|
COPD
|
COPD/CHF/Cirrhosis
| 6
| 14
|
under $11k
| 0
| 5,000
| 2,686.8398
| null | 17
|
hispanic
| 14.898438
| 34
| 0.911987
| 0.851929
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 3
| 83
| 7.699219
| 104
| 30
| 36.69531
| 271.375
| 4
| 0.699951
| 1.5
| 141
| 7.399414
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.956055
| 1,384
| 0
|
86.51099
|
female
| 0
| 7
|
Coma
|
Coma
| 1
| null |
under $11k
| 61
| 5,779
| 3,547.0391
| null | 4
|
white
| 14.699219
| 17
| 0.459961
| 0.386963
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr before sadm
| -1
| 97
| 19.296875
| 70
| 20
| 38.19531
| null | null | null | 0.899902
| 138
| null | null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 15
| 1
|
76.88397
|
male
| 0
| 12
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 7
|
under $11k
| 0
| 19,659
| 8,682.5469
| null | 19
|
other
| 23.296875
| 35
| 0.750977
| 0.605957
| 1
| 0
| 0
|
no
| 0.4
| 0.2
|
dnr before sadm
| -1
| 83
| 7.899414
| 100
| 25
| 36.09375
| 150
| null | null | 1.099854
| 138
| 7.30957
| null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 1,024
| 1
|
73.89996
|
female
| 0
| 22
|
Lung Cancer
|
Cancer
| 3
| 12
| null | 0
| 32,118
| 18,400.0938
| null | 9.333328
|
white
| 17.199219
| 18
| 0.682983
| 0.388977
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
dnr after sadm
| 5
| 103
| 2.399902
| 60
| 20
| 36.09375
| null | null | null | 0.799927
| 141
| null | null | null | null | 5
| 4
|
SIP>=30
| 4
| 174
| 1
|
41.57999
|
female
| 0
| 17
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 18
|
>$50k
| 0
| 35,673
| 20,488.1875
| null | 21.333328
|
white
| 35.695313
| 71
| 0.35199
| 0.234985
| 1
| 0
| 0
|
metastatic
| 0.98
| 0.85
|
no dnr
| 17
| 53
| 0.099991
| 124
| 35
| 38.5
| 228
| 2.199707
| 2.899902
| 0.899902
| 145
| 7.389648
| null | null | null | 0
| 0
|
SIP>=30
| 0
| 681
| 1
|
87.79498
|
female
| 0
| 12
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 13,337
| 7,492.2266
| null | 15.5
|
white
| 19.796875
| 49
| 0.728882
| 0.575928
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
dnr before sadm
| -1
| 117
| 4.5
| 70
| 40
| 36.09375
| 233.3125
| null | null | 1.599854
| 142
| 7.419922
| null | null | null | null | 3
|
no(M2 and SIP pres)
| 3
| 716
| 1
|
23.379
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
| null | 0
| 17,374
| 9,278.9297
| null | 13.5
|
white
| 27.398438
| 22
| 0.860962
| 0.812988
| 4
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 10
| 77
| 14.298828
| 110
| 30
| 38.89844
| 120
| 2.799805
| null | 0.799927
| 138
| 7.40918
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,378
| 0
|
84.12897
|
female
| 1
| 8
|
Coma
|
Coma
| 1
| 16
| null | 100
| 23,860
| 11,709.4297
| null | 26.5
|
white
| 34.59375
| 50
| 0
| 0
| 7
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 3
| 53
| 9.298828
| 110
| 35
| 35
| 140
| 3
| null | 1.199951
| 148
| 7.319336
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 8
| 1
|
94.26996
|
female
| 1
| 5
|
Coma
|
Coma
| 2
| 12
|
>$50k
| 100
| 5,610
| 3,407.0137
| null | 18
|
white
| 36
| 51
| 0
| 0
| 1
| 0
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 1
| 43
| 32.898438
| 70
| 30
| 35.59375
| 552
| 3.099609
| 0.699951
| 1.799805
| 151
| 7.609375
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 5
| 1
|
60.71698
|
male
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
| null | 0
| 83,838
| 49,739.8125
| null | 38
|
white
| 26.699219
| 39
| 0.766968
| 0.691895
| 2
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 25
| 63
| 14.199219
| 67
| 28
| 38.89844
| 96.65625
| 3.699707
| 0.899902
| 1.5
| 144
| 7.419922
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,377
| 0
|
83.97797
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 37,408
| 28,155.8281
| null | 47
|
white
| 49.296875
| 89
| 0.048996
| 0.014999
| 6
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 2
| 33
| 15.599609
| 140
| 18
| 39.19531
| 186.65625
| 1.899902
| 1.099854
| 6.799805
| 129
| 7.389648
| null | null | null | null | null |
<2 mo. follow-up
| 2.763672
| 5
| 1
|
94.06195
|
male
| 1
| 44
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
| null | 44
| 60,663
| 31,748.0469
| null | 18
|
white
| 33.398438
| 53
| 0.219971
| 0.121994
| 1
| 0
| 0
|
no
| 0.25
| 0.1
|
no dnr
| 44
| 47
| 10.798828
| 59
| 28
| 36.59375
| 519
| 2.399902
| 0.699951
| 3.299805
| 145
| 7.349609
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 44
| 1
|
74.42798
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 13
| null | 0
| 6,553
| 3,672.4277
| null | 6
|
white
| 20.398438
| 32
| 0.826904
| 0.718994
| 1
| 1
| 0
|
no
| 0.95
| 0.75
|
no dnr
| 6
| 73
| 5.5
| 60
| 15
| 35.59375
| 257.125
| 3.099609
| 0.599976
| 1.299805
| 143
| 7.479492
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.177734
| 719
| 1
|
72.70898
|
male
| 0
| 19
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 0
| 32,712
| 22,892.3594
| null | 22
|
white
| 20.796875
| 32
| 0.802979
| 0.682983
| 2
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 19
| 105
| 11.398438
| 81
| 10
| 38.19531
| 150
| 3.799805
| 0.599976
| 2
| 133
| 7.449219
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,020
| 1
|
76.849
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 9
| 43,883
| 32,881.8125
| null | 32
|
white
| 23.398438
| 39
| 0.61499
| 0.509888
| 9
| 0
| 1
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 6
| 57
| 12.699219
| 80
| 28
| 38.69531
| 157.125
| null | null | 0.699951
| 138
| 7.479492
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 7
| 1
|
76.435
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 12
|
under $11k
| 0
| 12,933
| 6,387.9922
| null | 14.5
|
white
| 33.5
| 55
| 0.482971
| 0.280945
| 1
| 1
| 0
|
yes
| 0.8
| 0.5
|
dnr before sadm
| -1
| 53
| 10.199219
| 70
| 25
| 36.09375
| 113.32812
| null | null | 2.299805
| 137
| 7.369141
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 472
| 1
|
77.74896
|
male
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$11-$25k
| 0
| 37,301
| 18,901.2188
| null | 21
|
white
| 34.796875
| 53
| 0.518921
| 0.402954
| 1
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 26
| 60
| 21.296875
| 140
| 12
| 36.39844
| 143.75
| null | null | 3.399902
| 147
| 7.459961
| null | null | null | null | null |
no(M2 and SIP pres)
| 3.675293
| 328
| 1
|
24.36699
|
male
| 1
| 9
|
Coma
|
Coma
| 0
| 16
| null | 100
| 32,558
| 21,909.3125
| null | 41
|
white
| 22.699219
| 30
| 0.638916
| 0.577881
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
dnr after sadm
| 8
| 125
| 5.099609
| 150
| 14
| 39.39844
| 196
| 2.5
| 0.599976
| 0.699951
| 145
| 7.419922
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
33.33899
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
$11-$25k
| 0
| 9,397
| 4,952.1719
| null | 12
|
hispanic
| 16.199219
| 16
| 0.939941
| 0.917969
| 1
| 1
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 8
| 83
| 7
| 70
| 20
| 36.09375
| 300
| 3.299805
| 1
| 0.899902
| 135
| 7.469727
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,371
| 0
|
67.948
|
female
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 0
| 3,707
| 2,003.1494
| null | 19
|
white
| 8.699219
| 11
| 0.938965
| 0.894897
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 3
| 80
| 6.699219
| 70
| 20
| 37.39844
| 240
| 4.299805
| null | 1.099854
| 144
| 7.40918
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,369
| 0
|
78.38495
|
female
| 0
| 42
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 37
| 55,119
| 31,046.0312
| null | 13.5
|
white
| 24.898438
| 37
| 0.602905
| 0.495972
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 3
| 61
| 11.5
| 55
| 12
| 36.09375
| 486.1875
| 2.899902
| 0.5
| 1.899902
| 148
| 7.369141
| null | null | null | null | null | null | 3.239258
| 1,369
| 0
|
70.00696
|
female
| 0
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 52,072
| 24,351.1875
| null | 21.25
|
white
| 28.398438
| 65
| 0.650879
| 0.55188
| 1
| 0
| 0
|
yes
| 0.9
| 0.9
|
no dnr
| 33
| 44
| 37.898438
| 78
| 40
| 38.59375
| 228.5625
| 1.899902
| 1.299805
| 1.399902
| 139
| 7.339844
| null | null | null | 2
| 1
|
no(M2 and SIP pres)
| 1
| 1,368
| 0
|
85.85394
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 9
| 16,619
| 9,151.375
| null | 14.5
|
white
| 31.5
| 43
| 0.511963
| 0.395996
| 1
| 1
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 13
| 53
| 4.199219
| 70
| 30
| 36.69531
| 105
| null | null | 0.899902
| 142
| 7.349609
| null | null | null | 2
| 5
|
<2 mo. follow-up
| 5
| 48
| 1
|
95.50995
|
male
| 1
| 8
|
Coma
|
Coma
| 1
| 15
|
$11-$25k
| 0
| 8,418
| 4,959.6328
| null | 14
|
white
| 21.199219
| 29
| 0.403992
| 0.329956
| 1
| 0
| 0
|
yes
| 0.01
| 0.000001
|
dnr before sadm
| -1
| 83
| 34.796875
| 100
| 30
| 38.59375
| null | 4.199219
| 1.099854
| 1.399902
| 136
| null | null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 8
| 1
|
61.57199
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 17,562
| 9,151.3125
| null | 18.5
|
white
| 17.296875
| 36
| 0.889893
| 0.850952
| 1
| 1
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 13
| 53
| 8
| 69
| 30
| 38.79688
| 264
| 3.199707
| 0.399963
| 0.899902
| 139
| 7.469727
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,367
| 0
|
76.67096
|
male
| 1
| 26
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
>$50k
| 9
| 28,454
| 17,808.5312
| null | 14.75
|
white
| 16.199219
| 22
| 0.850952
| 0.754883
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
dnr after sadm
| 10
| 73
| 8.398438
| 76
| 24
| 36.59375
| null | 3.299805
| 1.5
| 1.299805
| 136
| null | null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 26
| 1
|
65.88599
|
male
| 1
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 50,062
| 30,376.6094
| null | 29.333328
|
white
| 31.097656
| 55
| 0.678955
| 0.584961
| 1
| 0
| 0
|
no
| 0.5
| 0.7
|
dnr after sadm
| 19
| 45
| 11
| 72
| 38
| 38.5
| 244.4375
| 2.699707
| 1.099854
| 2.5
| 141
| 7.40918
| null | null | null | 3
| 3
|
<2 mo. follow-up
| 3
| 25
| 1
|
80.27698
|
female
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 4,464
| 2,597.1328
| null | 13
|
white
| 18.898438
| 21
| 0.797974
| 0.67395
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 4
| 107
| 11.398438
| 60
| 20
| 35.59375
| 332
| null | null | 1
| 140
| 7.359375
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,362
| 0
|
80.47095
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 19
|
under $11k
| 0
| 10,981
| 5,523.8789
| null | 5
|
white
| 14.099609
| 21
| 0.87793
| 0.796997
| 1
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 9
| 83
| 7
| 60
| 15
| 36.69531
| 410
| 4
| 0.5
| 1.699951
| 138
| 7.459961
| null | null | null | 6
| 1
|
no(M2 and SIP pres)
| 1
| 1,361
| 0
|
85.06494
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 5
|
$11-$25k
| 44
| 21,711
| 11,713.5469
| null | 17
|
white
| 20.398438
| 35
| 0.641968
| 0.540894
| 1
| 0
| 1
|
no
| 0.15
| 0.05
|
dnr after sadm
| 5
| 113
| 5.899414
| 110
| 30
| 38.09375
| 306.625
| 2.199707
| 1.899902
| 0.899902
| 144
| 7.419922
| null | null | null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 1,359
| 0
|
78.32196
|
male
| 0
| 12
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 16
|
$11-$25k
| 0
| 16,940
| 8,582.7422
| null | 16
|
white
| 28.199219
| 46
| 0.637939
| 0.45697
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 12
| 128
| 12.5
| 59
| 36
| 37.09375
| 172.5
| 3.399902
| 0.299988
| 3.399902
| 138
| 7.419922
| null | null | null | 0
| 0
|
SIP>=30
| 0
| 1,201
| 1
|
52.26797
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| null |
under $11k
| 0
| 3,133
| 1,922.8633
| null | 2
|
white
| 21.097656
| 6
| 0.653931
| 0.348999
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 83
| 11.398438
| 100
| 20
| 36.09375
| null | 3.299805
| 0.5
| 0.799927
| 138
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.172363
| 11
| 1
|
50.20898
|
female
| 0
| 14
|
Lung Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 0
| 17,041
| 10,160.3672
| null | 5.333332
|
white
| 4.299805
| 9
| 0.898926
| 0.766968
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.09
|
dnr after sadm
| 6
| 80
| 9.5
| 72
| 20
| 36.79688
| null | 4.699219
| 0.399963
| 0.5
| 135
| null | null | null | null | 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 108
| 1
|
63.228
|
male
| 1
| 11
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
>$50k
| 0
| 33,619
| 13,934.8281
| null | 50.5
|
white
| 42.09375
| 65
| 0.211975
| 0.116989
| 1
| 0
| 0
|
yes
| 0.2
| 0.1
|
dnr after sadm
| 8
| 53
| 2.899902
| 56
| 12
| 38.39844
| 63
| 3
| 2.199707
| 3.399902
| 138
| 7.339844
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 11
| 1
|
68.58899
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 17
|
$25-$50k
| 0
| 52,123
| 13,483.3047
| null | 17
|
white
| 16.398438
| 24
| 0.882935
| 0.841919
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 13
| 70
| 15.199219
| 70
| 22
| 38.5
| 484
| 3.399902
| 0.899902
| 1.5
| 136
| 7.439453
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 692
| 1
|
79.06897
|
female
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
| null | 0
| 12,777
| 7,161.125
| null | 9.5
|
white
| 15.099609
| 17
| 0.872925
| 0.78894
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 10
| 87
| 11.398438
| 80
| 20
| 36.69531
| 271.375
| null | null | 1.199951
| 141
| 7.419922
| null | null | null | 3
| 0
|
no(M2 and SIP pres)
| 0
| 114
| 1
|
83.39996
|
male
| 0
| 50
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 9
| 61,748
| 37,880.6562
| null | 10.75
|
white
| 32.695313
| 49
| 0.493958
| 0.375977
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
dnr after sadm
| 16
| 73
| 4.899414
| 137
| 40
| 36.09375
| null | 3.299805
| 1.399902
| 2.299805
| 150
| 7.449219
| null | null | null | null | 2
|
adl>=4 (>=5 if sur)
| 2
| 90
| 1
|
33.922
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 9
| 25,613
| 10,798.6406
| null | 17.333328
|
white
| 26.5
| 44
| 0.848999
| 0.796997
| 1
| 0
| 0
|
no
| 0.7
| 0.4
|
no dnr
| 17
| 65
| 16.5
| 130
| 24
| 38.09375
| 284
| 2.299805
| 8.298828
| 0.799927
| 141
| 7.549805
| null | null | null | null | null | null | 2.770508
| 299
| 1
|
63.29398
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 19
| null | 0
| 21,501
| 10,837.3281
| null | 27
|
white
| 22.699219
| 40
| 0.829956
| 0.772949
| 1
| 1
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 11
| 63
| 5.599609
| 80
| 14
| 36.79688
| 207.5
| 2.799805
| 0.5
| 5.899414
| 135
| 7.359375
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 498
| 1
|
96.42694
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 5,218
| 3,066.8047
| null | 15
|
white
| 16.796875
| 20
| 0.716919
| 0.559937
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 103
| 14.199219
| 80
| 20
| 36.69531
| 251.65625
| null | 1.299805
| 1.399902
| 144
| 7.329102
| null | null | null | null | null |
no(M2 and SIP pres)
| 3.303711
| 1,050
| 1
|
69.43994
|
male
| 1
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 9
|
under $11k
| 0
| 18,031
| 7,176.5977
| null | 34
|
white
| 33.296875
| 48
| 0.55188
| 0.353943
| 4
| 0
| 0
|
no
| 0.09
| 0.000729
|
no dnr
| 5
| 50
| 26
| 105
| 24
| 38
| 118.875
| null | null | 1.599854
| 136
| 7.259766
| null | null | null | null | null |
<2 mo. follow-up
| 2.71582
| 5
| 1
|
63.625
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 9
| 11,290
| 5,561.3125
| null | 9
|
white
| 16.796875
| 9
| 0.885986
| 0.80896
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 1
| 93
| 8.599609
| 100
| 20
| 36.69531
| 344.4375
| null | null | 0.799927
| 142
| 7.319336
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,349
| 0
|
69.30597
|
male
| 0
| 15
|
Coma
|
Coma
| 1
| 8
|
$11-$25k
| 100
| 28,125
| 19,160.1094
| null | 15.666664
|
black
| 26.597656
| 49
| 0.060997
| 0.032997
| 1
| 0
| 0
|
yes
| 0.05
| 0.000125
|
no dnr
| 15
| 74
| 10.5
| 74
| 42
| 36.39844
| 124
| 3.399902
| 2.199707
| 1.5
| 138
| 7.459961
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,349
| 0
|
85.51996
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 8
| null | 0
| 10,072
| 5,087.5469
| null | 12
|
white
| 20.199219
| 37
| 0.685913
| 0.592896
| 1
| 1
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 8
| 61
| 14.798828
| 58
| 30
| 36.09375
| 314.25
| 3.099609
| null | 1.099854
| 140
| 7.489258
| null | null | null | 1
| 0
| null | 0
| 349
| 1
|
81.44299
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 9
| 52,123
| 35,130.2812
| null | 24.666656
|
white
| 22.898438
| 29
| 0.598999
| 0.490967
| 9
| 0
| 0
|
yes
| 0.5
| 0.4
|
dnr after sadm
| 9
| 61
| 15
| 69
| 24
| 38.29688
| 106.65625
| 2.699707
| 0.699951
| 1.399902
| 135
| 7.509766
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,347
| 0
|
75.44098
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 16
|
$25-$50k
| 0
| 17,626
| 7,756.8359
| null | 13.5
|
black
| 29.796875
| 35
| 0.542969
| 0.428955
| 3
| 1
| 0
|
yes
| 0.95
| 0.93
|
no dnr
| 9
| 69
| 10.898438
| 70
| 14
| 36.19531
| 128
| 3.299805
| 1.299805
| 3.699707
| 141
| 7.449219
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,344
| 0
|
63.978
|
female
| 0
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 79,417
| 48,618.5312
| null | 27
|
white
| 21.5
| 40
| 0.789917
| 0.721924
| 14
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 35
| 77
| 16.5
| 80
| 4
| 36.39844
| 268
| null | null | 0.699951
| 139
| 7.389648
| null | null | null | 2
| 1
|
no(M2 and SIP pres)
| 1
| 269
| 1
|
38.80399
|
male
| 0
| 3
|
Colon Cancer
|
Cancer
| 1
| 10
|
$25-$50k
| 0
| 4,218
| 2,412.7617
| null | 12
|
white
| 17.796875
| 18
| 0.850952
| 0.669922
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.9
|
no dnr
| 3
| 99
| null | 120
| 26
| 37.89844
| null | 3.599609
| 0.899902
| 0.699951
| 136
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.734375
| 115
| 1
|
72.40497
|
female
| 0
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 5
| 12
| null | 0
| 16,955
| 6,938.1562
| null | 15
|
white
| 16
| 35
| 0.821899
| 0.761963
| 1
| 1
| 0
|
yes
| 0.98
| 0.8
|
no dnr
| 10
| 113
| 93.890625
| 85
| 34
| 38.09375
| 232.25
| 4.199219
| 0.199982
| 0.899902
| 140
| 7.359375
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 761
| 1
|
72.10095
|
male
| 1
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
| null | 0
| 29,317
| 17,072.7812
| null | 25
|
white
| 26
| 37
| 0.60498
| 0.497986
| 3
| 0
| 0
|
yes
| 0.01
| 0.000001
|
dnr after sadm
| 1
| 100
| 63
| 80
| 32
| 35.69531
| 161.21875
| null | null | 1.5
| 146
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
80.27399
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 2
| 16
|
>$50k
| 0
| 7,562
| 4,552.8359
| null | 2.5
|
white
| 13.699219
| 14
| 0.832886
| 0.635986
| 1
| 0
| 0
|
metastatic
| 0.98
| 0.8
|
no dnr
| 8
| 97
| 4.599609
| 80
| 20
| 36.69531
| null | null | null | 1.199951
| 140
| null | null | null | null | 3
| 1
|
no(M2 and SIP pres)
| 1
| 303
| 1
|
67.03595
|
male
| 1
| 8
|
Colon Cancer
|
Cancer
| 1
| 8
|
under $11k
| 0
| 16,195
| 9,882.6484
| null | 24
|
white
| 39.5
| 44
| 0.27594
| 0.040993
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.02
|
dnr after sadm
| 7
| 117
| 19.597656
| 110
| 30
| 35.69531
| 316.3125
| 2.699707
| 9.5
| 1.299805
| 136
| 7.40918
| null | null | null | 3
| 1
|
<2 mo. follow-up
| 1
| 8
| 1
|
43.66098
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
under $11k
| 0
| 19,138
| 9,625.2031
| null | 10.5
|
white
| 22.5
| 38
| 0.866943
| 0.819946
| 3
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 11
| 133
| 5.299805
| 80
| 20
| 36.69531
| null | 2.199707
| null | 5.299805
| 136
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 282
| 1
|
66.04498
|
male
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 16
| null | 0
| 11,598
| 3,684.0996
| null | 52
|
white
| 61
| 91
| 0
| 0
| 1
| 1
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 3
| 33
| 23.796875
| 40
| 44
| 36.39844
| 105
| 2.199707
| 2.199707
| 4.199219
| 127
| 7.389648
| null | null | null | null | null |
<2 mo. follow-up
| 2.175293
| 5
| 1
|
83.06396
|
male
| 0
| 12
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 17,204
| 10,102.1719
| null | 13.5
|
white
| 27.097656
| 44
| 0.344971
| 0.155975
| 1
| 0
| 0
|
yes
| 0.5
| 0.33
|
dnr after sadm
| 4
| 68
| 13.298828
| 60
| 20
| 35.59375
| null | null | 2
| 2.299805
| 131
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 65
| 1
|
89.67297
|
female
| 1
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 30
|
$25-$50k
| 9
| 19,612
| 5,866.1602
| null | 29
|
white
| 26.398438
| 44
| 0.539917
| 0.425964
| 2
| 0
| 0
|
yes
| 0.5
| 0.4
|
dnr after sadm
| 1
| 120
| 19.398438
| 78
| 28
| 37.89844
| 170
| null | 0.899902
| 4.199219
| 136
| 7.389648
| null | null | null | 1
| null |
<2 mo. follow-up
| 1.1669
| 10
| 1
|
84.51996
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 13
|
$11-$25k
| 0
| 5,884
| 4,059.6016
| null | 10
|
white
| 19.398438
| 30
| 0.756958
| 0.61499
| 1
| 0
| 0
|
yes
| 0.95
| 0.95
|
no dnr
| 5
| 117
| 9.298828
| 45
| 28
| 36.69531
| 223.3125
| 3.199707
| 0.399963
| 1.199951
| 143
| 7.369141
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,244
| 1
|
71.88794
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
| null | 0
| 4,909
| 3,153.375
| null | 14
|
white
| 22.097656
| 34
| 0.814941
| 0.699951
| 1
| 1
| 0
|
no
| 0.98
| 0.95
|
no dnr
| 6
| 83
| 5.399414
| 70
| 20
| 35.59375
| null | null | null | 2.199707
| 133
| null | null | null | null | 5
| null |
SIP>=30
| 3.855299
| 243
| 1
|
75.67395
|
female
| 0
| 47
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 61,867
| 35,709
| null | 18.25
|
white
| 36.398438
| 68
| 0.487
| 0.368958
| 1
| 0
| 0
|
no
| 0.75
| 0.6
|
dnr after sadm
| 3
| 45
| 25.199219
| 160
| 48
| 39.29688
| 342.8125
| 2.5
| 0.799927
| 1.899902
| 142
| 7.269531
| null | null | null | 1
| null |
<2 mo. follow-up
| 1.1669
| 54
| 1
|
100.13098
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 4
| null | 0
| 4,485
| 2,759.3106
| null | 6
|
black
| 15.199219
| 23
| 0.755981
| 0.613892
| 1
| 0
| 0
|
yes
| 0.7
| 0.6
|
no dnr
| 5
| 77
| 6
| 60
| 15
| 36.09375
| null | 3.699707
| null | 1.099854
| 141
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 3.382324
| 1,082
| 1
|
41.771
|
male
| 1
| 21
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 14
| null | 0
| 97,144
| 72,525.5625
| null | 44.333313
|
hispanic
| 24.097656
| 37
| 0.826904
| 0.718994
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
dnr after sadm
| 20
| 70
| 11.199219
| 70
| 10
| 38.09375
| 162
| 1.699951
| 5.5
| 0.799927
| 132
| 7.449219
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 21
| 1
|
54.36798
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 35,856
| 23,739.0781
| null | 31.333328
|
white
| 30.699219
| 64
| 0.699951
| 0.609985
| 4
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 14
| 61
| 7.599609
| 150
| 52
| 39.29688
| 102.5
| 2.5
| 0.399963
| 1.199951
| 134
| 7.229492
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,324
| 0
|
71.43896
|
female
| 0
| 19
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| 12
|
under $11k
| 0
| 25,724
| 12,041.1484
| null | 18.333328
|
white
| 21.597656
| 30
| 0.767944
| 0.630981
| 1
| 0
| 0
|
yes
| 0.6
| 0.5
|
dnr after sadm
| 7
| 100
| 12.298828
| 100
| 15
| 36.09375
| 355
| 3.799805
| 0.299988
| 2.599609
| 141
| 7.419922
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 34
| 1
|
66.10297
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 6,726
| 2,813.3965
| null | 15
|
white
| 18.898438
| 32
| 0.870972
| 0.785889
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 4
| 63
| 10.798828
| 54
| 14
| 36.29688
| 219.03125
| null | 1.399902
| 1.099854
| 142
| 7.379883
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,321
| 0
|
72.30096
|
male
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 9
| null | 0
| 63,943
| 28,989.6094
| null | 48.5
|
black
| 37.5
| 74
| 0.362
| 0.244995
| 15
| 1
| 0
|
no
| null | null |
dnr after sadm
| 9
| 63
| 30.097656
| 119
| 38
| 35.19531
| 151.65625
| 2.199707
| 1
| 7.799805
| 132
| 7.319336
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 12
| 1
|
72.81
|
female
| 1
| 10
|
Coma
|
Coma
| 4
| 12
|
under $11k
| 61
| 20,721
| 7,335.1953
| null | 31.5
|
white
| 38.59375
| 60
| 0.025997
| 0.011
| 1
| 1
| 1
|
no
| 0.1
| 0.001
|
dnr after sadm
| 9
| 43
| 22.398438
| 120
| 28
| 38.69531
| 324.4375
| 2.199707
| null | 3.699707
| 142
| 7.379883
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 10
| 1
|
75.258
|
male
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 34,405
| 13,343.0625
| null | 42.5
|
white
| 34.5
| 36
| 0.386963
| 0.267944
| 5
| 0
| 0
|
yes
| 0.5
| 0.5
|
dnr after sadm
| 5
| 44
| 21.398438
| 108
| 16
| 38.19531
| 135
| null | null | 1.199951
| 145
| 7.399414
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
74.72699
|
female
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 35,196
| 12,690.6484
| null | 40.5
|
white
| 38.195313
| 70
| 0.366943
| 0.248993
| 5
| 1
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 2
| 49
| 14.298828
| 120
| 34
| 38.29688
| 148.3125
| 2.899902
| 0.199982
| 3.399902
| 136
| 7.359375
| null | null | null | null | null |
<2 mo. follow-up
| 2.500488
| 10
| 1
|
66.97095
|
female
| 0
| 18
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
| null | 0
| 26,628
| 12,572.0234
| null | 12
|
white
| 18.796875
| 18
| 0.868896
| 0.781982
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 18
| 62
| 8.398438
| 110
| 8
| 37.89844
| 162.5
| 3.799805
| 0.899902
| 0.899902
| 143
| 7.349609
| null | null | null | 3
| 4
|
no(M2 and SIP pres)
| 4
| 1,315
| 0
|
87.86298
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 28,359
| 18,643.0156
| null | 15.333328
|
white
| 33.5
| 63
| 0.458984
| 0.338989
| 2
| 0
| 0
|
no
| 0.85
| 0.5
|
dnr before sadm
| -1
| 53
| 5.199219
| 66
| 36
| 35.59375
| 188
| 3.599609
| 0.799927
| 7.199219
| 137
| 7.329102
| null | null | null | 4
| null |
no(M2 and SIP pres)
| 3.183199
| 1,314
| 0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.